MindMed to Present at Canaccord Genuity’s 44th A
Post# of 64
https://www.businesswire.com/news/home/20240806945771/en/
August 06, 2024 04:01 PM Eastern Daylight Time
NEW YORK--(BUSINESS WIRE)--Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the “Company” or “MindMed”), a clinical-stage biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced that members of the Company’s management team will present at Canaccord Genuity’s 44th Annual Growth Conference:
Canaccord Genuity’s 44th Annual Growth Conference
Format: Fireside Chat
Date and Time: Tuesday, August 13, 2024 at 1:30 PM ET
Location: Boston, MA
Webcast Link: Canaccord Genuity’s 44th Annual Growth Conference - https://wsw.com/webcast/canaccord98/register....md/2458676
Audio webcasts and replays of available presentations will be accessible on MindMed’s Investor Relations website for up to 90 days following the event.